Allscripts Healthcare Solutions, Inc. (MDRX - Analyst Report) , a leading player in the health care information technology (HCIT) market, recently reported that Salford Royal NHS Foundation Trust installed the Allscripts Sunrise Clinical Manager (SCM). The installation of this acute care Electronic Health Record occurred around Jun 8, 2013 without time and cost overruns.
Salford Royal has used an Electronic Patient Record for more than 10 years. Its adoption of SCM will enable it to provide enhanced care to almost 240,000 patients.
Salford Royal transferred about a million patient records to the new technology. It also shifted 180 million orders, results and documents.
Sunrise Clinical Manager has a sophisticated Computerized Provider Order Entry, acute critical care offerings and other advanced features.
Salford Royal NHS Foundation Trust is a composite provider of hospital and other services, including its University Teaching Hospital. It provides services to both the City of Salford and Greater Manchester area in the UK.
We are of the opinion that acute and ambulatory care will continue to converge in the future. Also, Allscripts is positioned to provide integrated clinical applications for health care providers to satisfy their requirements and eventually comply with an outcomes-based reimbursement system.
As a potential takeover target, Allscripts presents a lucrative opportunity for firms seeking entry into the HCIT industry. It has a wide user base and enjoys many opportunities vis-à-vis its peers. Its mergers with Misys and Eclipsys have expanded opportunities and reach in practice management (“PM”) and Electronic Health Record (“EHR”) markets substantially and increased cross-selling opportunities. We believe that Allscripts is well positioned in the fast growing business of selling EHR to physician practices as well as inpatient settings.
The HCIT market is competitive and price sensitive. Among others, Allscripts faces strong competition from Cerner Corporation (CERN - Analyst Report) , Quality Systems Inc. (QSII - Analyst Report) and Athenahealth, Inc. (ATHN - Analyst Report) . The stock carries a Zacks Rank #3 (Hold).